Cited by

• Increased Incidence and Associated Risk Factors of Aspergillosis in Patients with Bronchiectasis.

  Yang B, Kim T, Ryu J, Park HY, Hwangbo B, Kong SY, Kwon YS, Lee SJ, Ra SW, Oh YM, Sohn JW, Choe KH, Choi H, Lee H. Yang B, et al. J Pers Med. 2021 May 17;11(5):422. doi: 10.3390/jpm11050422. J Pers Med. 2021. PMID: 34067607 Free PMC article.
• Aspergilloma and massive haemoptysis.

  Ding WY, Chan T, Yadavilli RK, McWilliams R. Ding WY, et al. BMJ Case Rep. 2014 Apr 16;2014:bcr2013200019. doi: 10.1136/bcr-2013-200019. BMJ Case Rep. 2014. PMID: 24739651 Free PMC article.
• Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis.

  Denning DW, Pleuvry A, Cole DC. Denning DW, et al. Bull World Health Organ. 2011 Dec 1;89(12):864-72. doi: 10.2471/BLT.11.089441. Epub 2011 Sep 27. Bull World Health Organ. 2011. PMID: 22271943 Free PMC article.
• Clinical profile of pulmonary aspergilloma complicating residual tubercular cavitations in Northen Indian patients.

  Gupta PR, Vyas A, Meena RC, Sharma S, Khayam N, Subramanian IM, Kanoongo D, Solanki V, Bansal A. Gupta PR, et al. Lung India. 2010 Oct;27(4):209-11. doi: 10.4103/0970-2113.71947. Lung India. 2010. PMID: 21139716 Free PMC article.
• Evaluation of the Double Agar Gel Immunodiffusion Test and of the Enzyme-Linked Immunosorbent Assay in the Diagnosis and Follow-Up of Patients with Chronic Pulmonary Aspergillosis.

  de Azevedo PZ, Sylvestre TF, Cavalcante Rde S, de Carvalho LR, Moris DV, de Oliveira ML, Mendes RP. de Azevedo PZ, et al. PLoS One. 2015 Aug 13;10(8):e0134841. doi: 10.1371/journal.pone.0134841. eCollection 2015. PLoS One. 2015. PMID: 26271000 Free PMC article. Clinical Trial.